Phase 2 trial of induction with dasatinib and consolidation with hyper-CVAD plus dasatinib followed by allografting for Ph-positive acute lymphoblastic leukemia in adults

IF 2.1 4区医学 Q3 HEMATOLOGY Leukemia research Pub Date : 2024-02-01 DOI:10.1016/j.leukres.2024.107438

Iekuni Oh, Kaoru Hatano, Takashi Ikeda, Yumiko Toda, Daisuke Minakata, Shinichiro Kawaguchi, Kaoru Morita, Chihiro Yamamoto, Masahiro Ashizawa, Kazuya Sato, Kazuaki Kameda, Ayumi Gomyo, Yukiko Misaki, Shunto Kawamura, Shunichi Kimura, Hiroyuki Kobayashi, Hiroyuki Sato, Hideki Nakasone, Ken Ohmine, Shinichiro Fujiwara, Yoshinobu Kanda

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

用达沙替尼诱导和超CVAD加达沙替尼巩固治疗成人Ph阳性急性淋巴细胞白血病并进行异体移植的2期试验

无摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Leukemia research 医学-血液学

CiteScore

4.00

自引率

3.70%

发文量

259

审稿时长

1 months

期刊介绍： Leukemia Research an international journal which brings comprehensive and current information to all health care professionals involved in basic and applied clinical research in hematological malignancies. The editors encourage the submission of articles relevant to hematological malignancies. The Journal scope includes reporting studies of cellular and molecular biology, genetics, immunology, epidemiology, clinical evaluation, and therapy of these diseases.